Literature DB >> 7598144

Bloodstream invasion in early Lyme disease: results from a prospective, controlled, blinded study using the polymerase chain reaction.

J L Goodman1, J F Bradley, A E Ross, P Goellner, A Lagus, B Vitale, B W Berger, S Luger, R C Johnson.   

Abstract

PURPOSE: The purposes of this study were to determine (1) the optimal techniques for and potential diagnostic usefulness of the polymerase chain reaction (PCR) in early Lyme disease, and (2) the true frequency and clinical correlates of PCR-documented blood-borne infection in the dissemination of Lyme disease. PATIENTS AND METHODS: We performed a prospective, controlled, blinded study of PCR, culture, and serology on fractionated blood samples from 105 patients; 76 with physician-diagnosed erythema migrans and 29 controls. Clinical characteristics of the patients were obtained with a standardized data entry form and correlated with results of the laboratory studies.
RESULTS: Only 4 of the 76 (5.3%) patients with erythema migrans were culture positive; however, 14 of 76 (18.4%) had spirochetemia documented by PCR of their plasma. None of 29 controls were PCR or culture positive (P = 0.007, versus patients). PCR-documented spirochetemia correlated with clinical evidence of disseminated disease; 10 of 33 patients (30.3%) with systemic symptom(s) were PCR positive compared to 4 of 43 (9.3%) without such evidence (P = 0.02). PCR positivity was more frequent among patients with each of four specific symptoms: fever, arthralgia, myalgia, and headache (all P < 0.05). A higher total number of symptoms (median 2.5 in PCR-positive patients versus 0 in PCR-negative controls; P < 0.01) and the presence of multiple skin lesions (37.5% of patients with multiple, versus 13.3% of patients with single lesions [P = 0.04] were also correlated with PCR positivity. Patients with both systemic symptoms and multiple skin lesions had a 40% PCR-positivity rate; however, 4 of 42 (9.5%) asympatomatic patients with only single erythema migrans lesions were also PCR positive. In multivariate analysis using logistic regression, the number of systemic symptoms was the strongest independent predictor of PCR positivity (P = 0.004).
CONCLUSIONS: PCR detection of Borrelia burgdorferi is at least three times more sensitive than culture for identifying spirochetemia in early Lyme disease and may be useful in rapid diagnosis. PCR positivity significantly correlates with clinical evidence of disease dissemination. Bloodstream invasion is an important and common mechanism for the dissemination of the Lyme disease spirochete.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7598144     DOI: 10.1016/s0002-9343(99)80097-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  34 in total

1.  PCR-Based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-Day postinfection period.

Authors:  R K Straubinger
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Rapid diagnosis of bacteremia by universal amplification of 23S ribosomal DNA followed by hybridization to an oligonucleotide array.

Authors:  R M Anthony; T J Brown; G L French
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Improving the yield of blood cultures from patients with early Lyme disease.

Authors:  Dionysios Liveris; Ira Schwartz; Susan Bittker; Denise Cooper; Radha Iyer; Mary E Cox; Gary P Wormser
Journal:  J Clin Microbiol       Date:  2011-04-13       Impact factor: 5.948

4.  An optimized PCR leads to rapid and highly sensitive detection of Borrelia burgdorferi in patients with Lyme borreliosis.

Authors:  S Priem; M G Rittig; T Kamradt; G R Burmester; A Krause
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

5.  Comparison of the yields of blood cultures using serum or plasma from patients with early Lyme disease.

Authors:  G P Wormser; S Bittker; D Cooper; J Nowakowski; R B Nadelman; C Pavia
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

6.  Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment.

Authors:  R K Straubinger; B A Summers; Y F Chang; M J Appel
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

7.  Borrelia burgdorferi genetic markers and disseminated disease in patients with early Lyme disease.

Authors:  Kathryn L Jones; Lisa J Glickstein; Nitin Damle; Vijay K Sikand; Gail McHugh; Allen C Steere
Journal:  J Clin Microbiol       Date:  2006-10-11       Impact factor: 5.948

8.  T2 Magnetic Resonance Assay-Based Direct Detection of Three Lyme Disease-Related Borrelia Species in Whole-Blood Samples.

Authors:  Jessica L Snyder; Heidi Giese; Cheryl Bandoski-Gralinski; Jessica Townsend; Beck E Jacobson; Robert Shivers; Anna M Schotthoefer; Thomas R Fritsche; Clayton Green; Steven M Callister; John A Branda; Thomas J Lowery
Journal:  J Clin Microbiol       Date:  2017-05-31       Impact factor: 5.948

9.  Host DNA can interfere with detection of Borrelia burgdorferi in skin biopsy specimens by PCR.

Authors:  F B Cogswell; C E Bantar; T G Hughes; Y Gu; M T Philipp
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

10.  Diagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis.

Authors:  S Brettschneider; H Bruckbauer; N Klugbauer; H Hofmann
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.